Digital tool for men with early prostate cancer
Part of Cancer, Kidney & urinary clinical trials.
This study tests a digital tool to help men with early prostate cancer make treatment decisions. It aims to see if the tool improves communication and support during this stressful time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with prostate cancer that has not spread.
- Your Gleason score is 8 or lower and your PSA level is less than 30.
- You are able to read and understand English or Spanish.
- You have access to the internet and the Epic MyChart patient portal.
- You are willing to participate in the study and visit a participating site.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a digital support tool that helps you understand your prostate cancer diagnosis and treatment options. It uses artificial intelligence to guide you through educational materials and connect you with support resources.
This trial tests a computer tool that analyzes your conversations with doctors. It aims to help you make a more informed choice about prostate cancer treatment.
This study tests an artificial intelligence (AI) tool that may improve how doctors detect prostate cancer using imaging and biopsy information. It could help better identify cancer that is suspected based on PSA blood tests and rectal exam findings.
This study is testing an AI tool that helps explain prostate biopsy results in a way that is easier to understand. If you join, you'll review your pathology report with the help of this tool to see if it improves your understanding of your diagnosis.
This trial tests an English computer tool that gives feedback during prostate cancer treatment visits. It aims to help you and your clinician make more informed, shared decisions about next treatment steps.
This early-phase study uses a tiny implant placed during prostate cancer surgery planning to help researchers measure how tumors respond to treatment while still in the body. The results may help improve future treatment choices for men with intermediate- or high-risk prostate cancer.
Hear when a new Prostate cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.